Please use this identifier to cite or link to this item: https://doi.org/10.1096/fj.202002185RR
Title: Maternal microchimerism and cell-mediated immune-modulation enhance engraftment following semi-allogenic intrauterine transplantation
Authors: Kandasamy, Karthikeyan 
Tan, Lay Geok 
Johana, Nuryanti B
Tan, Yi Wan
Foo, Wanling
Yeo, Julie SL
Ravikumar, Vikashini
Ginhoux, Florent
Choolani, Mahesh 
Chan, Jerry KY 
Mattar, Citra NZ 
Keywords: Science & Technology
Life Sciences & Biomedicine
Biochemistry & Molecular Biology
Biology
Cell Biology
Life Sciences & Biomedicine - Other Topics
bone marrow cells
fetal therapy
hematopoietic stem and progenitor cells
intrauterine transplantation
maternal donor cells
paternal donor cells
semi&#8208
allogenic donor cells
BONE-MARROW-TRANSPLANTATION
HEMATOPOIETIC STEM-CELLS
REGULATORY T-CELLS
PRENATAL TOLERANCE INDUCTION
VERSUS-HOST-DISEASE
CANINE MODEL
CHIMERISM
DELETION
ANTIGENS
MHC
Issue Date: Mar-2021
Publisher: WILEY
Citation: Kandasamy, Karthikeyan, Tan, Lay Geok, Johana, Nuryanti B, Tan, Yi Wan, Foo, Wanling, Yeo, Julie SL, Ravikumar, Vikashini, Ginhoux, Florent, Choolani, Mahesh, Chan, Jerry KY, Mattar, Citra NZ (2021-03). Maternal microchimerism and cell-mediated immune-modulation enhance engraftment following semi-allogenic intrauterine transplantation. FASEB JOURNAL 35 (3). ScholarBank@NUS Repository. https://doi.org/10.1096/fj.202002185RR
Abstract: Successful intrauterine hematopoietic cell transplantation (IUT) for congenital hemoglobinopathies is hampered by maternal alloresponsiveness. We investigate these interactions in semi-allogenic murine IUT. E14 fetuses (B6 females × BALB/c males) were each treated with 5E+6 maternal (B6) or paternal (BALB/c) bone marrow cells and serially monitored for chimerism (>1% engraftment), trafficked maternal immune cells, and immune responsiveness to donor cells. A total of 41.0% of maternal IUT recipients (mIUT) were chimeras (mean donor chimerism 3.0 ± 1.3%) versus 75.0% of paternal IUT recipients (pIUT, 3.6 ± 1.1%). Chimeras showed higher maternal microchimerism of CD4, CD8, and CD19 than non-chimeras. These maternal cells showed minimal responsiveness to B6 or BALB/c stimulation. To interrogate tolerance, mIUT were injected postnatally with 5E+6 B6 cells/pup; pIUT received BALB/c cells. IUT-treated pups showed no changes in trafficked maternal or fetal immune cell levels compared to controls. Donor-specific IgM and IgG were expressed by 1%-3% of recipients. mIUT splenocytes showed greater proliferation of regulatory T cells (Treg) upon BALB/c stimulation, while B6 stimulation upregulated the pro-inflammatory cytokines more than BALB/c. pIUT splenocytes produced identical Treg and cytokine responses to BALB/c and B6 cells, with higher Treg activity and lower pro-inflammatory cytokine expression upon exposure to BALB/c. In contrast, naïve fetal splenocytes demonstrated greater alloresponsiveness to BALB/c compared to B6 cells. Thus pIUT, associated with increased maternal cell trafficking, modulates fetal Treg, and cytokine responsiveness to donor cells more efficiently than mIUT, resulting in improved engraftment. Paternal donor cells may be considered alternatively to maternal donor cells for intrauterine and postnatal transplantation to induce tolerance and maintain engraftment.
Source Title: FASEB JOURNAL
URI: https://scholarbank.nus.edu.sg/handle/10635/245757
ISSN: 0892-6638
1530-6860
DOI: 10.1096/fj.202002185RR
Appears in Collections:Staff Publications
Elements

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
Kandasamy et al_FASEB_2021.pdfPublished version2.55 MBAdobe PDF

OPEN

PublishedView/Download

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.